«TAVR» İLE İLİŞKİLİ İNGILIZCE KİTAPLAR
TAVR sözcüğünün kullanımını aşağıdaki kaynakça seçkisinde keşfedin.
TAVR ile ilişkili kitaplar ve İngilizce edebiyattaki kullanımı ile ilgili bağlam sağlaması için küçük metinler.
1
Catheter Interventions for Structural Heart Disease, An ...
TAVR has emerged as a viable therapeutic alternative to SAVR. Initial single and
multicenter experiences showed that this procedure is both safe and efficacious.”
59 Among patients with severe AS at prohibitive surgical risk, results of The ...
2
Critical Care Medicine: Principles of Diagnosis and ...
PARTNER B randomized patients with suitable vasculature to transfemoral TAVR
versus medical therapy.67 Patients who received only medical therapy (with or
without balloon valvuloplasty) had a 51% 1-year mortality rate compared to those
...
Joseph E. Parrillo, R. Phillip Dellinger, 2013
At 1 year, the rate of death from any cause was 30.7% with TAVR compared to
50.7% with standard therapy including balloon valvuloplasty. The rate of the
composite end point of death from any cause or repeat hospitalization was 42.5%
with ...
Kanu Chatterjee, Phillip A. Horwitz, 2014
4
Interventional Procedures for Adult Structural Heart ...
ACC, America College of Cardiology; AHA, American Heart Association; AS,
aortic stenosis; AVR, aortic valve replacement (surgical). candidates for surgical
AVR or TAVR should be offered palliative BAV in place of medical therapy alone.
John M Lasala, Jason H. Rogers, 2013
5
Cardiovascular Clinical Trials: Putting the Evidence into ...
prospective trial included 119 patients undergoing TAVR and 104 SAVR, all of
whom had chronic kidney disease pre-procedure [76]. Inevitably those selected
to undergo TAVR were older with more comorbidities, as well as higher baseline
...
Marcus Flather, Deepak Bhatt, Tobias Geisler, 2012
6
Endovascular and Hybrid Therapies for Structural Heart and ...
Cohort B results In Cohort B, TAVR was superior to medical therapy and/or
balloon aortic valvuloplasty for all-cause mortality at 1 year (31% versus 51%, P <
0.001, number needed to treat (NNT):5) and at 2 years (43% versus 68%, P <
0.001, ...
Jacques Kpodonu, Raoul Bonan, 2013
7
Renal Complications in the Catheterization Laboratory, An ...
In one studyof234patientswho underwent TAVR between 2007 and 2010 at a
single center, preTAVR creatinine was the only independent predictor of AKI
using multivariable logistic regression analysis.13 There is alsosome suggestion
that a ...
8
Heart Valves—Advances in Research and Application: 2013 Edition
For high-risk patients with severe AS, TAVR has been shown to result in similar
12-month survival but differing adverse events compared with AVR.” The news
correspondents obtained a quote from the research from Medical City Dallas ...
9
Atherothrombosis in Clinical Practice
CHAPTER 3 Valvular Heart Disease H published in the FDA executive summary
(updated june 2011) was even higher: 7.3 percent at 30 days and 11.2 percent at
1 year.50 Some of the increased stroke effect with TAVR in cohort B may simply ...
10
Aortic Stenosis: New Insights for the Healthcare ...
According to news reporting from Neptune, New Jersey, by NewsRx journalists,
research stated, “This study sought to evaluate the impact of frailty in older adults
undergoing transcatheter aortic valve replacement (TAVR) for symptomatic aortic
...
«TAVR» TERİMİNİ İÇEREN HABERLER
Ulusal ve uluslararası basında konuşulanları ve
TAVR teriminin aşağıdaki haberlerde hangi bağlamda kullanıldığını keşfedin.
Medtronics CoreValve Evolut R TAVR System Wins FDA Nod
In recent times, the TAVR procedure has emerged as a convenient and popular ... Mectronic's CoreValve portfolio as a suitable alternative for TAVR in high-risk ... «Zacks.com, Haz 15»
FDA Approves New CoreValve TAVR Device
The CoreValve Evolut-R system is approved for transcatheter aortic valve replacement (TAVR) in severe aortic stenosis patients who are at high or extreme risk ... «MedPage Today, Haz 15»
FDA OK for St. Jude to Resume Portico TAVR Trial
June 3, 2015 (updated June 4) -- Today St. Jude Medical announced FDA approval to resume their U.S. IDE trial for the Portico Transcatheter Aortic Valve ... «Angioplasty.Org, Haz 15»
FDA: Use of TAVR system expanded to include aortic valve-in-valve …
The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press release. «Healio, Mar 15»
NOTION: TAVR, Surgery Comparable in Low-Risk Patients
While the TAVR group had more conduction abnormalities and greater total aortic-valve regurgitation, the SAVR group had more episodes of major bleeding, ... «Medscape, Mar 15»
TAVR: A New Heart Procedure
A Luzerne County man who wouldn't have been a candidate for heart surgery got the help he needed using a fairly new procedure. It's a way to repair a heart ... «wnep.com, Mar 15»
ACC: TAVR Embolic Protection Device Promising
SAN DIEGO -- An experimental embolic protection device for transcatheter aortic valve replacement (TAVR) reduced clinically-silent embolic lesions in the brain, ... «MedPage Today, Mar 15»
One-Year, Real-World TAVR Data Help Identify Risks, Benefits
ROCHESTER, MN — In a study of more than 12 000 patients who underwent transcatheter aortic-valve replacement (TAVR) in clinical practice in the US, 1 year ... «Medscape, Mar 15»
High Risks And Rewards Found With Heart Valve Device From …
Transcatheter aortic valve replacement (TAVR) is one of the most important advances in cardiovascular medicine in recent years. TAVR devices, introduced ... «Forbes, Mar 15»
Pulmonary hypertension frequent comorbidity in patients with aortic …
All patients underwent TAVR with the Sapien or Sapien XT heart valves (Edwards Lifesciences) or the CoreValve (Medtronic) from 2007 to 2013 at MedStar ... «Healio, Mar 15»
